Significant Ownership of Casdin Capital, LLC

Signature - Title
/s/ Eli Casdin* - Eli Casdin, Managing Member
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Casdin Capital, LLC.

Notify me when Casdin Capital, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Casdin Capital, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LAB Standard BioTools Inc. Common Stock, $0.001 par value per share 24% $107,459,205 +$14,465,243 93,442,787 +16% Eli Casdin 25 Nov 2025
BLFS BioLife Solutions, Inc. Common Stock, par value $0.001 per share 12% $151,967,279 -$19,132,500 5,957,165 -11% Casdin Capital, LLC 15 Oct 2025
NGNE Neurogene Inc. Common Stock, $0.000001 par value 8.7% $19,961,513 1,295,361 Casdin Capital, LLC 31 Dec 2024
TNYA Tenaya Therapeutics, Inc. Common Stock, $0.0001 par value per share 4.3% $3,231,826 6,732,971 Casdin Capital, LLC 04 Mar 2025
IPSC Century Therapeutics, Inc. Common Stock, $0.0001 par value per share 3.7% $1,702,527 3,212,316 Casdin Capital, LLC 31 Mar 2025
CDXS Codexis, Inc. Common Stock, par value $0.0001 per share 0% $0 -$17,568,000 0 -100% CASDIN CAPITAL, LLC 30 Sep 2025

Schedules 13D/G Reported by Casdin Capital, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.